Identification | Back Directory | [Name]
BAY-1895344 | [CAS]
1876467-74-1 | [Synonyms]
CPD1213 Elimusertib BAY-1895344 Elimusertib free base BAY-1895344 HCl(Elimusertib) BAY1895344;BAY 1895344;CPD1213 BAY1895344;BAY 1895344;BAY-1895344 (R)-3-methyl-4-(4-(1-methyl-1H-pyrazol-5-yl)-8-(1H-pyrazol-3-yl)-1,7-naphthyridin-2-yl)morpholine (R)-3-methyl-4-(4-(1-methyl-1H-pyrazol-5-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl)morpholine 1,7-Naphthyridine, 2-[(3R)-3-methyl-4-morpholinyl]-4-(1-methyl-1H-pyrazol-5-yl)-8-(1H-pyrazol-3-yl)- | [Molecular Formula]
C20H21N7O | [MDL Number]
MFCD31561442 | [MOL File]
1876467-74-1.mol | [Molecular Weight]
375.43 |
Chemical Properties | Back Directory | [Melting point ]
>200°C (dec.) | [Boiling point ]
661.1±55.0 °C(Predicted) | [density ]
1.43±0.1 g/cm3(Predicted) | [storage temp. ]
Hygroscopic, -20°C Freezer, Under inert atmosphere | [solubility ]
Acetonitrile (Slightly), DMSO (Slightly), Methanol (Slightly) | [form ]
Solid | [pka]
11.09±0.10(Predicted) | [color ]
Orange |
Hazard Information | Back Directory | [Uses]
BAY-1895344 is a selective ATR (ataxia-telangiectasia and Rad3 related protein) inhibitor used in the treatment of advanced hyperproliferative disease, prophylaxis, solid tumors and lymphomas. | [storage]
Store at -20°C |
|
|